A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetyl cholinesterase inhibitor, in patients with mild to mederatey severe Alzheimer's disease. - Corey-Bloom,J.; Anand,R.; Veach,J. (Int J Geriatr Psychopharmacol, 1998)